Griffin: Framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
Doebley, A.-L.; Ko, M.; Liao, H.; Cruikshank, A. E.; Kikawa, C.; Santos, K.; Hiatt, J.; Patton, R. D.; De Sarkar, N.; Hoge, A. C.; Chen, K.; Weber, Z. T.; Adil, M.; Reichel, J.; Polak, P.; Adalsteinsson, V. A.; Nelson, P. S.; Parsons, H. A.; Stover, D. G.; MacPherson, D.; Ha, G.
Show abstract
Cell-free DNA (cfDNA) has the potential to inform tumor subtype classification and help guide clinical precision oncology. Here we developed Griffin, a new method for profiling nucleosome protection and accessibility from cfDNA to study the phenotype of tumors using as low as 0.1x coverage whole genome sequencing (WGS) data. Griffin employs a novel GC correction procedure tailored to variable cfDNA fragment sizes, which improves the prediction of chromatin accessibility. Griffin achieved excellent performance for detecting tumor cfDNA in early-stage cancer patients (AUC=0.96). Next, we applied Griffin for the first demonstration of estrogen receptor (ER) subtyping in metastatic breast cancer from cfDNA. We analyzed 254 samples from 139 patients and predicted ER subtype with high performance (AUC=0.89), leading to insights about tumor heterogeneity. In summary, Griffin is a framework for accurate clinical subtyping and can be generalizable to other cancer types for precision oncology applications.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Evolution of chromosome arm aberrations in breast cancer through genetic network rewiring 96%
- Interrogation of cancer gene dependencies reveals novel paralog interactions of autosome and sexchromosome encoded genes 96%
- Genetic dependencies associated with transcription factor activities in human cancer cell lines 96%
Similar papers in this journal
- Impact of genome build on RNA-seq interpretation and diagnostics 95%
- Misexpression of inactive genes in whole blood is associated with nearby rare structural variants 95%
- Characterization of non-coding variants associated with transcription factor binding through ATAC-seq-defined footprint QTLs in liver 95%
Similar papers in this journal
- Prioritization of enhancer mutations by combining allele-specific chromatin accessibility with deep learning 97%
- Comprehensive analysis of structural variants in breast cancer genomes using single molecule sequencing 97%
- Quantitative occupancy of myriad transcription factors from one DNase experiment enables efficient comparisons across conditions 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.